Related references
Note: Only part of the references are listed.Therapeutic peptides: current applications and future directions
Lei Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
In Vivo Human Single-Chain Fragment Variable Phage Display-Assisted Identification of Galectin-3 as a New Biomarker of Atherosclerosis
Audrey Hemadou et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening
Sandra Isabel Aguiar et al.
PHARMACEUTICS (2021)
CAR-T cell therapy: current limitations and potential strategies
Robert C. Sterner et al.
BLOOD CANCER JOURNAL (2021)
Animal- versus in vitro-derived antibodies: avoiding the extremes
Andrew R. M. Bradbury et al.
MABS (2021)
V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation
Xiying Chi et al.
IMMUNOLOGY (2020)
Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives
Hilal Ahmed Parray et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Animal-derived-antibody generation faces strict reform in accordance with European Union policy on animal use
Alison C. Gray et al.
NATURE METHODS (2020)
Animal-free alternatives and the antibody iceberg
Alison Gray et al.
NATURE BIOTECHNOLOGY (2020)
Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
Mohamed A. Alfaleh et al.
FRONTIERS IN IMMUNOLOGY (2020)
The 2018 Nobel Prize in Chemistry: phage display of peptides and antibodies
Rodrigo Barderas et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)
ALTHEA Gold Libraries™: antibody libraries for therapeutic antibody discovery
Philippe Valadon et al.
MABS (2019)
Coupling brain perfusion screens and next generation sequencing to identify blood-brain barrier binding antibodies
Charles C. Stutz et al.
AICHE JOURNAL (2018)
An innovative flow cytometry method to screen human scFv-phages selected by in vivo phage-display in an animal model of atherosclerosis
Audrey Hemadou et al.
SCIENTIFIC REPORTS (2018)
Albumin-binding domain from Streptococcus zooepidemicus protein Zag as a novel strategy to improve the half-life of therapeutic proteins
Catia Cantante et al.
JOURNAL OF BIOTECHNOLOGY (2017)
Advance in phage display technology for bioanalysis
Yuyu Tan et al.
BIOTECHNOLOGY JOURNAL (2016)
In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150Glued
Sanne A. M. van Lith et al.
ONCOTARGET (2016)
Targeting membrane proteins for antibody discovery using phage display
Martina L. Jones et al.
SCIENTIFIC REPORTS (2016)
Advance in phage display technology for bioanalysis
Yuyu Tan et al.
BIOTECHNOLOGY JOURNAL (2016)
Antibody-Drug Conjugates in Cancer Therapy
Eric L. Sievers et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Albumin as a versatile platform for drug half-life extension
Darrell Sleep et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
In vivo phage display - A discovery tool in molecular biomedicine
Janka Babickova et al.
BIOTECHNOLOGY ADVANCES (2013)
A novel peptide specifically targeting ovarian cancer identified by in vivo phage display
Chuying Ma et al.
JOURNAL OF PEPTIDE SCIENCE (2013)
New Human Antibody Fragments Homing to Atherosclerotic Endothelial and Subendothelial Tissues An in Vivo Phage Display Targeting Human Antibodies Homing to Atherosclerotic Tissues
Kamel Deramchia et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
By-Passing Large Screening Experiments Using Sequencing as a Tool to Identify scFv Fragments Targeting Atherosclerotic Lesions in a Novel In Vivo Phage Display Selection
Kamel Deramchia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Strategies for extended serum half-life of protein therapeutics
Roland E. Kontermann
CURRENT OPINION IN BIOTECHNOLOGY (2011)
Efficient In Vivo Selection of a Novel Tumor-Associated Peptide from a Phage Display Library
Anka N. Veleva et al.
MOLECULES (2011)
Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients
Fernanda I. Staquicini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Phage display: Concept, innovations, applications and future
Jyoti Pande et al.
BIOTECHNOLOGY ADVANCES (2010)
Parallel in Vivo and in Vitro Selection Using Phage Display Identifies Protease-dependent Tumor-targeting Peptides
Mike Whitney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Phage library-screening: A powerful approach for generation of targeting-agents specific for normal pancreatic islet-cells and islet-cell carcinoma in vivo
S. Ueberberg et al.
REGULATORY PEPTIDES (2010)
Generation of Novel Single-Chain Antibodies by Phage-Display Technology to Direct Imaging Agents Highly Selective to Pancreatic β- or α-Cells In Vivo
Sandra Ueberberg et al.
DIABETES (2009)
Recombinant antibodies as therapeutic agents - Pathways for modeling new biodrugs
Frederico Aires da Silva et al.
BIODRUGS (2008)
Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV)
Martina Inga Kirsch et al.
BMC BIOTECHNOLOGY (2008)
Non-specific translocation of peptide-displaying bacteriophage particles across the gastrointestinal barrier
Maryam Hamzeh-Mivehroud et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
An entirely cell-based system to generate single-chain antibodies against cell surface receptors
Barbara D. Lipes et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
A novel tri-functional antibody fusion protein with improved pharmacokinetic properties generated by fusing a bispecific single-chain diabody with an albumin-binding domain from streptococcal protein G
Roland Stork et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2007)
Identification of human scFvs targeting atherosclerotic lesions -: Selection by single round in vivo phage display
Remy Robert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Identification of oligopeptides binding to peritoneal tumors of gastric cancer
Noriyuki Akita et al.
CANCER SCIENCE (2006)
Engineering of therapeutic antibodies to minimize immunogenicity and optimize function
Leonard G. Presta
ADVANCED DRUG DELIVERY REVIEWS (2006)
Selection of tumor-binding ligands in cancer patients with phage display libraries
David N. Krag et al.
CANCER RESEARCH (2006)
Affinity maturation of phage display antibody populations using ribosome display
Maria Groves et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Synchronous selection of homing peptides for multiple tissues by in vivo phage display
Mikhail G. Kolonin et al.
FASEB JOURNAL (2006)
Immunogenicity of engineered antibodies
WYK Hwang et al.
METHODS (2005)
Engineered antibody fragments and the rise of single domains
P Holliger et al.
NATURE BIOTECHNOLOGY (2005)
Selecting and screening recombinant antibody libraries
HR Hoogenboom
NATURE BIOTECHNOLOGY (2005)
Identification of peptide sequences that induce the transport of phage across the gastrointestinal mucosal barrier
DM Duerr et al.
JOURNAL OF VIROLOGICAL METHODS (2004)
Combinatorial screenings in patients:: The interleukin-11 receptor α as a candidate target in the progression of human prostate cancer
AJ Zurita et al.
CANCER RESEARCH (2004)
Camelized rabbit-derived VH single-domain Intrabodies Against vif strongly neutralize HIV-1 infectivity
FA da Silva et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Antibodies from phage antibody libraries
ARM Bradbury et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Immunological factors that affect the in vivo fate of T7 phage in the mouse
AS Srivastava et al.
JOURNAL OF VIROLOGICAL METHODS (2004)
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells
P Laakkonen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mapping alveolar binding sites in vivo using phage peptide libraries
M Wu et al.
GENE THERAPY (2003)
Engineered antibodies
Peter J. Hudson et al.
NATURE MEDICINE (2003)
Domain antibodies: proteins for therapy
LJ Holt et al.
TRENDS IN BIOTECHNOLOGY (2003)
Albumin binding as a general strategy for improving the pharmacokinetics of proteins
MS Dennis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Formatting antibody fragments to mediate specific therapeutic functions
ANC Weir et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments:: a clinical phase I/II study
JL Casey et al.
BRITISH JOURNAL OF CANCER (2002)
Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature
M Essler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Targeting the prostate for destruction through a vascular address
W Arap et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Uptake and processing of modified bacteriophage M13 in mice: Implications for phage display
TJM Molenaar et al.
VIROLOGY (2002)
Steps toward mapping the human vasculature by phage display
W Arap et al.
NATURE MEDICINE (2002)
A helper phage to improve single-chain antibody presentation in phage display
S Rondot et al.
NATURE BIOTECHNOLOGY (2001)
In vivo selection of sFv from phage display libraries
M Johns et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2000)
Share Paper
